510(k) Report

510(k) · Cleared

Cleared

Accu-Chek Safe-T-Pro Plus Lancing Device

K232488510(k) TraditionalCleared Nov 13, 202388-day reviewClass II21 CFR 878.4850

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diabetes Care, Inc. · FMK Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature

Cleared on Nov 13, 2023 as substantially equivalent to K220849 (Roche Diabetes Care, Inc., 2022) after an 88-day review. Its family tree reaches back 3 generations to 1982.

Decided
Nov 13, 2023
Review
88 days
Class
Class II
Product code
FMK
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K822209 (1982). No later device cites it as a predicate yet.

  1. Root · 3 generations backK822209 AutolancetBd Becton Dickinson Vacutainer Systems Preanalytic · 1982
  2. 2 generations backK101145 Surgilance Safety Lancets, Models SLN100, SLN200, SLN240, SLN300…Medipurpose Pte., Ltd. · 2010
  3. 1 generation backK220849 Accu-Chek Safe-T-Pro Plus Lancing DeviceRoche Diabetes Care, Inc. · 2022
  4. This deviceK232488 Accu-Chek Safe-T-Pro Plus Lancing DeviceRoche Diabetes Care, Inc. · 2023
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K822209AutolancetBd Becton Dickinson Vacutainer Systems Preanalytic1982—
−2K101145Surgilance Safety Lancets, Models SLN100, SLN200, SLN240, SLN300, SLB200, SLB250Medipurpose Pte., Ltd.2010—
−1K220849Accu-Chek Safe-T-Pro Plus Lancing DeviceRoche Diabetes Care, Inc.2022—
0 (this device)K232488Accu-Chek Safe-T-Pro Plus Lancing DeviceRoche Diabetes Care, Inc.2023—
FIG. 1 — Lineage of K232488, 1982–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FMK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FMK device

  1. #1 K220370 Safety Lancet (XIII, XVII, XXI, XXII, XXIII…score 25.0 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K220849Accu-Chek Safe-T-Pro Plus Lancing Device
Summary page 4
…integral sharps injury prevention feature Regulation Number: 878.4850, Class II Product Code: FMK Legally Marketed Predicate Devices [21 CFR 807.92(a)(3)] Predicate #1: K220849 Predicate Trade Name: Accu-Chek Safe-T-Pro Plus Lancing Device Product Code: FMK Legally Marketed Reference Devices [21 CFR 807.…
Roche Diabetes Care, Inc.2022—
†K222090Safety LancetNingbo Medsun Medical Co., Ltd.2022—
†K221433Facet 28G Universal LancetFacet Technologies, LLC2022—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 41 years and passes through 3 companies; a new generation was cleared every 11.6 years on median.
  • None of the 3 ancestors has a recall.

How does its category compare?

All FMK devices

FMK Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · FMK

4in 2025

2010: 22012: 22013: 12016: 12017: 12019: 22021: 12022: 252023: 102024: 102025: 42026 (partial year): 5
2007high 25 (2022) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FMK

59in 2025

2022: 87 days median2023: 95 days median2024: 57 days median2025: 59 days median2026 (partial year): 68 days median
2007high 95 (2023) · low 57 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FMK

1in 2009

2007: 42008: 22009: 1
2007high 4 (2007) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FMK

47in 2025

2007: 1,2062008: 1,1002009: 8822010: 9102011: 1,4932012: 1,5732013: 1,3012014: 8902015: 7812016: 5392017: 5312018: 5342019: 3992020: 3132021: 2452022: 2542023: 2822024: 2432025: 47
2007high 1,573 (2012) · low 47 (2025)2025

MAUDE reports naming product code FMK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—41,206
20080—21,100
20090—1882
20102—0910
20110—01,493
20122—01,573
20131—01,301
20140—0890
20150—0781
20161—0539
20171—0531
20180—0534
20192—0399
20200—0313
20211—0245
202225870254
202310950282
202410570243
2025459047
20265680—

What is it indicated for?

The Accu-Chek Safe-T-Pro Plus lancing device is intended to produce a capillary blood sample for testing utilizing small amounts of blood.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K232488: Accu-Chek Safe-T-Pro Plus Lancing Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K232488

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026